{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T02:59:54Z","timestamp":1776049194080,"version":"3.50.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CONACyT","award":["40883"],"award-info":[{"award-number":["40883"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.pnpbp.2013.02.007","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T17:36:08Z","timestamp":1361208968000},"page":"154-161","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Sex differences in lipid peroxidation and fatty acid levels in recent onset schizophrenia"],"prefix":"10.1016","volume":"44","author":[{"given":"Julieta","family":"Ramos-Loyo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Medina-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna","family":"Estarr\u00f3n-Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Canales-Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulises","family":"G\u00f3mez-Pinedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis F.","family":"Cerd\u00e1n-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2013.02.007_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/eurpub\/4.1.27","article-title":"Determinants of selected unhealthy eating behaviours among male and female adults","volume":"4","author":"Abel","year":"1994","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0010","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0278-5846(02)00220-8","article-title":"The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant\/antioxidant imbalance","volume":"26","author":"Akyol","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.007_bb0015","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/JME-10-0122","article-title":"Selective estrogen receptor modulators as brain therapeutic agents","volume":"46","author":"Arevalo","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(02)01443-9","article-title":"Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients","volume":"53","author":"Arvindakshan","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.007_bb0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/09540260600583072","article-title":"Bioactive lipids in schizophrenia","volume":"18","author":"Berger","year":"2006","journal-title":"Int Rev Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.007_bb0030","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: an integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.007_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/157015911795596595","article-title":"Oxidative stress in schizophrenia","volume":"9","author":"Bo\u0161kovi\u0107","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0167-5699(94)90018-3","article-title":"Oxidative stress as a mediator of apoptosis","volume":"15","author":"Buttke","year":"1994","journal-title":"Immunol Today"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0361-9230(01)00551-2","article-title":"The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects","volume":"56","author":"Carver","year":"2001","journal-title":"Brain Res Bull"},{"issue":"5","key":"10.1016\/j.pnpbp.2013.02.007_bb0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1503\/jpn.090083","article-title":"Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness","volume":"35","author":"Che","year":"2010","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0055","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3346\/jkms.2009.24.6.1083","article-title":"Gender Difference in the prodromal symptoms of first-episode schizophrenia","volume":"24","author":"Choi","year":"2009","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0060","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1600-0447.1988.tb06388.x","article-title":"Fat consumption and schizophrenia","volume":"78","author":"Christensen","year":"1988","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.007_bb0065","first-page":"237","article-title":"Oxidative stress in schizophrenia - focusing on the main markers","volume":"23","author":"Ciobica","year":"2011","journal-title":"Psychiatr Danub"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.007_bb0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0019-5545.39753","article-title":"Evaluation of antioxidant deficit in schizophrenia","volume":"50","author":"Dadheech","year":"2008","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0075","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pnpbp.2012.06.010","article-title":"Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia","volume":"42","author":"Das UN","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2013.02.007_bb0080","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/jn\/124.12.2466","article-title":"Chronic dietary a-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats","volume":"124","author":"Delion","year":"1994","journal-title":"J Nutr"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0085","unstructured":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). Masson, S.A. (ed.) Barcelona Espa\u00f1a; 2003."},{"issue":"7","key":"10.1016\/j.pnpbp.2013.02.007_bb0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/09537100500128872","article-title":"Oxidative stress in blood platelets from schizophrenic patients","volume":"16","author":"Dietrich-Muszalska","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000202822","article-title":"Oxidative\/nitrative modifications of plasma proteins and thiols from patients with schizophrenia","volume":"59","author":"Dietrich-Muszalska","year":"2009","journal-title":"Neuropsychobiology"},{"issue":"6","key":"10.1016\/j.pnpbp.2013.02.007_bb0100","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.pnpbp.2005.04.034","article-title":"Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia","volume":"29","author":"du Bois","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2013.02.007_bb0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.jcp.0000177668.42640.fe","article-title":"Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients","volume":"25","author":"Fehsel","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-3223(99)00092-X","article-title":"Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia","volume":"47","author":"Fenton","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/JCP.0b013e318248b7bb","article-title":"Eicosapentaenoic acid interventions in schizophrenia. Meta-analysis of randomized, placebo- controlled studies","volume":"32","author":"Fusar-Poli","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0125","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.pnpbp.2005.11.009","article-title":"Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine","volume":"30","author":"Gama","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(94)00060-L","article-title":"Increased platelet phospholipase A2 activity in schizophrenia","volume":"16","author":"Gattaz","year":"1995","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/S0101-60832002000600002","article-title":"Schizophrenia: do men and women suffer from the same disease?","volume":"29","author":"H\u00e4fner","year":"2002","journal-title":"Rev Psiq Clin"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1192\/bjp.162.1.80","article-title":"The influence of age and sex on the onset and early course of schizophrenia","volume":"162","author":"H\u00e4fner","year":"1993","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0130","first-page":"1","article-title":"Hormonal aspects of schizophrenias: an overview","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0006-3223(02)01549-4","article-title":"Smoking, gender and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder","volume":"53","author":"Hibbeln","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","article-title":"The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia","volume":"30","author":"Horrobin","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0150","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0006-3223(91)90235-E","article-title":"Fatty acid levels in brains of schizophrenics and normal controls","volume":"30","author":"Horrobin","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014The final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3181\/00379727-185-42547","article-title":"Sex differences in n-3 and n-6 fatty acid metabolism in EFA-depleted rats","volume":"185","author":"Huang","year":"1987","journal-title":"Proc Soc Exp Biol Med (NY)"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2013.02.007_bb0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.schres.2008.04.035","article-title":"Corpus callosal area differences and gender dimorphism in neuroleptic-na\u00efve, recent-onset schizophrenia and healthy control subjects","volume":"103","author":"John","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.psychres.2009.01.013","article-title":"Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism","volume":"175","author":"Kale","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0180","first-page":"1","article-title":"A simplified method for analysis of polyunsatured fatty acids","author":"Kang","year":"2005","journal-title":"BMC Biochem"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0190","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/(SICI)1097-4547(19991215)58:6<823::AID-JNR9>3.0.CO;2-T","article-title":"4-hydroxynonenal increases neuronal susceptibility to oxidative stress","volume":"58","author":"Keller","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0195","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0006-3223(00)00940-9","article-title":"Magnetic resonance spectroscopy in schizophrenia methodological issues and findings\u2014Part II","volume":"48","author":"Keshavan","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.007_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00334-6","article-title":"Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics","volume":"58","author":"Khan","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0074-7742(09)88003-3","article-title":"Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity","volume":"88","author":"Kita","year":"2009","journal-title":"Int Rev Neurobiol"},{"issue":"5","key":"10.1016\/j.pnpbp.2013.02.007_bb0210","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1289\/ehp.98106s51179","article-title":"Impact of oxidative stress on signal transduction control by phosphotyrosine phosphatases","volume":"106","author":"Krejsa","year":"1998","journal-title":"Environ Health Perspect"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.007_bb0215","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/jnp.17.2.227","article-title":"Oxidative stress during treatment with first- and second-generation antipsychotics","volume":"17","author":"Kropp","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/schbul\/16.2.195","article-title":"Sexual dimorphism, brain morphology, and schizophrenia","volume":"16","author":"Lewine","year":"1990","journal-title":"Schizophr Bull"},{"issue":"12","key":"10.1016\/j.pnpbp.2013.02.007_bb0225","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1631\/jzus.2006.B0981","article-title":"Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study","volume":"7","author":"Li","year":"2006","journal-title":"J Zhejiang Univ Sci B"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2013.02.007_bb0230","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.schres.2009.12.009","article-title":"Cognitive differences between men and women: a comparison of patients with schizophrenia and healthy volunteers","volume":"120","author":"Longenecker","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(95)00049-6","article-title":"Free radical pathology and antioxidant defense in schizophrenia: a review","volume":"19","author":"Mahadik","year":"1996","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0245","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0006-3223(97)00282-5","article-title":"Elevated plasma lipid peroxides at the onset of nonaffective psychosis","volume":"43","author":"Mahadik","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.007_bb0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1176\/appi.neuropsych.11070154","article-title":"Olfaction and cognition in schizophrenia: sex matters","volume":"24","author":"Malaspina","year":"2012","journal-title":"Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.007_bb0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pnpbp.2006.07.010","article-title":"Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview","volume":"31","author":"Mazza","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0235","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/schbul\/16.2.319","article-title":"Gender differences in affective, schizoaffective, and schizophrenic disorders","volume":"16","author":"McGlashan","year":"1990","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0260","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.schres.2006.11.027","article-title":"Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications","volume":"91","author":"McNamara","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0265","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpsychires.2006.02.010","article-title":"Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics","volume":"41","author":"Medina-Hern\u00e1ndez","year":"2007","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.007_bb0270","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/JGP.0b013e3182011b7f","article-title":"Schizophrenia spectrum disorders in later life: prevalence and distribution of age at onset and sex in a dutch catchment area","volume":"20","author":"Meesters","year":"2012","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0275","first-page":"11","article-title":"Reduced antioxidant defense in early onset first-episode psychosis: a case\u2013control study","volume":"14","author":"Mic\u00f3","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0280","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pnpbp.2007.08.003","article-title":"Altered antioxidant defenses system in clinically stable patients with schizophrenia and their unaffected sibilings","volume":"32","author":"Othmen","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0285","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overrall","year":"1962","journal-title":"Psych Rep"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0290","series-title":"Colorimetric assay for lipid peroxidation product No. FR 12","first-page":"1","author":"Oxford Biomedical Research","year":"2003"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0295","first-page":"95","article-title":"Relationship between aging and susceptibility to oxidative damage: an assessment by erythrocyte membrane proteins and lipids","volume":"31","author":"Ozaydin","year":"2001","journal-title":"Turk J Med Sci"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.007_bb0300","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neulet.2010.05.088","article-title":"Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics","volume":"479","author":"Padurariu","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0310","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0140-6736(87)92987-4","article-title":"Evidence of enhanced lipid peroxidation in the cerebrospinal fluid patients taking phenothiazines","volume":"12","author":"Pall","year":"1987","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.007_bb0315","first-page":"157","article-title":"Oxidative stress as marker of positive symptoms in schizophrenia","volume":"9","author":"Pavlovi\u0107","year":"2002","journal-title":"Facta Universitatis"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0305","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1530-0277.1999.tb04115.x","article-title":"Alcohol consumption in rhesus monkeys depletes tissues of polyunsaturated fatty acids and alters essential fatty acid metabolism","volume":"23","author":"Pawlosky","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"10.1016\/j.pnpbp.2013.02.007_bb0320","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1440-1819.2009.02015.x","article-title":"Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile","volume":"63","author":"Pazvantoglu","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"issue":"6","key":"10.1016\/j.pnpbp.2013.02.007_bb0325","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jpsychires.2012.03.019","article-title":"Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity","volume":"46","author":"Pedrini","year":"2012","journal-title":"J Psychiatr Res"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.007_bb0520","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-3956(95)00001-L","article-title":"Depleted red cell membrane essential fatty acids in drug treated schizophrenic patients","volume":"29","author":"Peet","year":"1995","journal-title":"J Psychiatr Res"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.007_bb0335","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0920-9964(00)00083-9","article-title":"Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia","volume":"49","author":"Peet","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0340","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archpsyc.1991.01810300075011","article-title":"Alterations in brain high energy phosphate and membrane phospholipid metabolism in first episode, drug na\u00efve schizophrenics","volume":"48","author":"Pettegrew","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0355","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0891-5849(89)90041-5","article-title":"Peroxidation induced changes in synaptosomal transport of dopamine and y-aminobutyric acid","volume":"6","author":"Rafalowska","year":"1989","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0345","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.pnpbp.2009.06.018","article-title":"Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients","volume":"33","author":"Raffa","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.007_bb0350","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pnpbp.2012.07.013","article-title":"Reduced antioxidant defense systems in schizophrenia and bipolar I disorder","volume":"39","author":"Raffa","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0360","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/584725","article-title":"Sex differences in facial, prosodic and social context emotional recognition in early onset schizophrenia","author":"Ramos-Loyo","year":"2012","journal-title":"Schizophr Res Treat"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","article-title":"Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients","volume":"121","author":"Ranjekar","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0370","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0306-4530(02)00126-9","article-title":"Effects of estrogen on brain development and neuroprotection-implications for negative symptoms in schizophrenia","volume":"28","author":"Rao","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2013.02.007_bb0375","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0952-3278(96)90143-X","article-title":"Free radical pathology in schizophrenia: a review","volume":"55","author":"Reddy","year":"1996","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0380","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-9964(02)00407-3","article-title":"Reduced plasma antioxidants in first episode patients with schizophrenia","volume":"62","author":"Reddy","year":"2003","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.007_bb0385","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2217\/whe.09.75","article-title":"Omega-3 fatty acids and cognitive function in women","volume":"6","author":"Robinson","year":"2010","journal-title":"Womens Health (Lond Engl)"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0395","first-page":"1121","article-title":"Antioxidant status and other biochemical parameters in schizoprenia","volume":"114","author":"Ro\u015foiu","year":"2007","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0390","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-8993(99)01123-3","article-title":"Differential alteration of phospholipase A2 activities in brains of patients with schizophrenia","volume":"821","author":"Ross","year":"1999","journal-title":"Brain Res"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2013.02.007_bb0400","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.psychres.2012.07.024","article-title":"Adaptive response in the antioxidant defense system in the course and outcome in first-episode schizophrenia patients: A 12-months follow-up study","volume":"200","author":"Ruiz-Litago","year":"2012","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.007_bb0405","first-page":"206","article-title":"Age of onset symptoms and gender in schizophrenic spectrum disorders","volume":"32","author":"S\u00e1nchez","year":"2012","journal-title":"Biomedica"},{"issue":"6","key":"10.1016\/j.pnpbp.2013.02.007_bb0410","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.pnpbp.2007.03.008","article-title":"Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment","volume":"31","author":"Sarandol","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0415","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1440-1681.2007.04643.x","article-title":"Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease","volume":"34","author":"Sartori-Valinotti","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0420","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0006-3223(96)00300-9","article-title":"Sex differences in olfactory identification and Wisconsin Card Sorting performance in schizophrenia: relationship to attention and verbal ability","volume":"42","author":"Seidman","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0425","first-page":"82","article-title":"Oxidative stress in neurodegenerative diseases","volume":"36","author":"Simonian","year":"1996","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0430","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.plefa.2003.08.008","article-title":"From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?","volume":"69","author":"Skosnik","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0435","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"10.1016\/j.pnpbp.2013.02.007_bb0440","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/13543784.16.10.1627","article-title":"Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations","volume":"16","author":"Song","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0445","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0888-7543(87)90005-X","article-title":"Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21","volume":"1","author":"Sparkes","year":"1987","journal-title":"Genomics"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0450","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/00048679609065026","article-title":"Outcome of schizophrenia: the Madras longitudinal study","volume":"30","author":"Thara","year":"1996","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0455","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.psychres.2010.11.009","article-title":"Sex differences in cognition among persons with schizophrenia and healthy first-degree relatives","volume":"188","author":"Torniainen","year":"2011","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.1016\/j.pnpbp.2013.02.007_bb0465","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1440-1819.2006.01532.x","article-title":"Total antioxidant response in patients with schizophrenia","volume":"60","author":"Ustundag","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2013.02.007_bb0460","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2012.08.014","article-title":"A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia","volume":"141","author":"van der Kemp","year":"2012","journal-title":"Schizophr Res"},{"issue":"2","key":"10.1016\/j.pnpbp.2013.02.007_bb0470","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000239684","article-title":"A defect in the antioxidant defense system in schizophrenia","volume":"60","author":"Virit","year":"2009","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1016\/j.pnpbp.2013.02.007_bb0475","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jnr.10668","article-title":"Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide","volume":"73","author":"Wei","year":"2003","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.007_bb0480","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pnpbp.2011.08.018","article-title":"Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: inverse association with positive symptoms","volume":"36","author":"Wu","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0485","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-9964(01)00394-2","article-title":"31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospolipid and high-energy phosphate metabolism","volume":"58","author":"Yacubian","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0490","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-1781(98)00051-1","article-title":"Reduced level of plasma antioxidant uric acid","volume":"80","author":"Yao","year":"1998","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0495","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-1781(00)00230-4","article-title":"Abnormal age-related changes of plasma antioxidant proteins in schizophrenia","volume":"97","author":"Yao","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0500","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0006-3223(02)01397-5","article-title":"Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites","volume":"52","author":"Yao","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.02.007_bb0505","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","article-title":"Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics","volume":"81","author":"Zhang","year":"2006","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2013.02.007_bb0510","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11427-010-0013-8","article-title":"A meta-analysis of oxidative stress markers in schizophrenia","volume":"53","author":"Zhang","year":"2010","journal-title":"Sci China Life Sci"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2013.02.007_bb0515","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2012.04.009","article-title":"Plasma total antioxidant status and cognitive impairments in schizophrenia","volume":"139","author":"Zhang","year":"2012","journal-title":"Schizophr Res"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T21:02:12Z","timestamp":1562706132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584613000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":103,"alternative-id":["S0278584613000419"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.02.007","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}